Companies with normal risk readings
Companies with normal risk readings: 4,581 companies ranked by a composite risk reading built from filed statements -- leverage, cash conversion, operating pressure, customer and supplier concentration and competitive position. Recomputed 23 October 2026.
Composite readings for 14,903 companies, recomputed 23 October 2026. A company appears here once at least three weighted categories cleared their inputs; the rest carry per-mechanism readings without a headline.
| Company | Reading | Band | Sector | Country | Coverage | Market cap |
|---|---|---|---|---|---|---|
| J. Molner MOLNR.TL | 36 | Normal | -- | -- | 3 / 6 | $43M |
| Cocorport, Inc. 9346.T | 28 | Normal | Industrials | Japan | 5 / 6 | $43M |
| Hongxing Coldchain (Hunan) Co., Ltd. 1641.HK | 35 | Normal | Industrials | China | 5 / 6 | $43M |
| COM.TEL CMTL.MI | 38 | Normal | Technology | Italy | 5 / 6 | $43M |
| VisasQ Inc. 4490.T | 29 | Normal | Industrials | Japan | 5 / 6 | $42M |
| BIKE O & COMPANY Ltd. 3377.T | 21 | Normal | Consumer Cyclical | Japan | 5 / 6 | $42M |
| GMO Product Platform, Inc. 3695.T | 38 | Normal | Technology | Japan | 5 / 6 | $42M |
| MITRA Group, Inc. 6093.T | 34 | Normal | Industrials | Japan | 5 / 6 | $42M |
| ContextVision AB CONTX | 23 | Normal | Healthcare | Sweden | 4 / 6 | $42M |
| Xtant Medical Holdings Inc XTNT | 37 | Normal | Healthcare | United States | 6 / 6 | $42M |
| Enogia SAS ALENO | 29 | Normal | Industrials | France | 4 / 6 | $42M |
| Pacific Net Co.,Ltd. 3021.T | 34 | Normal | Technology | Japan | 5 / 6 | $42M |
| Sunright Limited S71.SI | 36 | Normal | Technology | Singapore | 4 / 6 | $42M |
| G.H.Y Culture & Media Holding Co., Limited XJB.SI | 38 | Normal | Communication Services | Singapore | 5 / 6 | $42M |
| IFIS Japan Ltd. 7833.T | 30 | Normal | Industrials | Japan | 5 / 6 | $42M |
| Simonds Group Limited SIO.AX | 28 | Normal | Consumer Cyclical | Australia | 3 / 6 | $42M |
| ABL Diagnostics ABLD.PA | 36 | Normal | Healthcare | France | 5 / 6 | $41M |
| UMP Healthcare Holdings Limited 0722.HK | 34 | Normal | Healthcare | Hong Kong | 4 / 6 | $41M |
| Forward Fashion (International) Holdings Company Limited 2528.HK | 30 | Normal | Consumer Cyclical | Hong Kong | 5 / 6 | $41M |
| Sakura Rubber Co., Ltd. 5189.T | 37 | Normal | Consumer Cyclical | Japan | 5 / 6 | $41M |
| Cryosite Limited CTE.AX | 20 | Normal | Healthcare | Australia | 4 / 6 | $41M |
| Sportsfield Co., Ltd. 7080.T | 21 | Normal | Industrials | Japan | 5 / 6 | $41M |
| Okumura Engineering corp. 6229.T | 28 | Normal | Industrials | Japan | 5 / 6 | $41M |
| CCID Consulting Company Limited 2176.HK | 25 | Normal | Industrials | China | 5 / 6 | $41M |
| Zixin Group Holdings Limited 42W.SI | 31 | Normal | Consumer Defensive | Singapore | 5 / 6 | $41M |
| Tsit Wing International Holdings Limited 2119.HK | 39 | Normal | Consumer Defensive | Hong Kong | 5 / 6 | $41M |
| MEMSCAP REGPT MEMS.PA | 34 | Normal | Technology | France | 5 / 6 | $41M |
| Artini Holdings Limited 0789.HK | 33 | Normal | Consumer Cyclical | Hong Kong | 5 / 6 | $41M |
| Estelle Holdings Co.,Ltd. 7872.T | 38 | Normal | Consumer Cyclical | Japan | 5 / 6 | $41M |
| Progress Technologies Group, Inc. 339A.T | 23 | Normal | Technology | Japan | 5 / 6 | $41M |
| SHIKIGAKU. Co., Ltd. 7049.T | 30 | Normal | Industrials | Japan | 5 / 6 | $41M |
| Huaxi Holdings Company Limited 1689.HK | 39 | Normal | Consumer Cyclical | Hong Kong | 5 / 6 | $41M |
| Little Green Pharma Ltd LGP | 22 | Normal | Healthcare | Australia | 4 / 6 | $41M |
| DNXcorp ALDNX | 30 | Normal | Communication Services | Luxembourg | 5 / 6 | $41M |
| HABA Laboratories,Inc. 4925.T | 32 | Normal | Consumer Defensive | Japan | 5 / 6 | $40M |
| Petro-king Oilfield Services Limited 2178.HK | 37 | Normal | Energy | China | 5 / 6 | $40M |
| Yue Da International Holdings Limited 0629.HK | 37 | Normal | Industrials | Hong Kong | 5 / 6 | $40M |
| Shigematsu Works Co., Ltd. 7980.T | 34 | Normal | Healthcare | Japan | 5 / 6 | $40M |
| NAP Nyilvánosan Működő Részvénytársaság NAP.BD | 30 | Normal | Utilities | Hungary | 5 / 6 | $40M |
| CRI Middleware Co., Ltd. 3698.T | 25 | Normal | Communication Services | Japan | 5 / 6 | $40M |
| CellSource Co., Ltd. 4880.T | 34 | Normal | Healthcare | Japan | 5 / 6 | $40M |
| Bilendi ALBLD | 38 | Normal | Communication Services | France | 5 / 6 | $40M |
| FLECT Co., Ltd. 4414.T | 30 | Normal | Technology | Japan | 5 / 6 | $40M |
| EnBio Holdings, Inc 6092.T | 32 | Normal | Industrials | Japan | 5 / 6 | $39M |
| B.M.P. PHARMA TRAD (BMP.SG) BMP | 39 | Normal | Healthcare | Germany | 4 / 6 | $39M |
| Zhong Ji Longevity Science Group Limited 0767.HK | 39 | Normal | Healthcare | Hong Kong | 5 / 6 | $39M |
| Health In Tech Inc - Class A HIT | 38 | Normal | Technology | United States | 6 / 6 | $39M |
| WDB coco Co., Ltd. 7079.T | 24 | Normal | Healthcare | Japan | 5 / 6 | $39M |
| Synectics plc SNX.L | 26 | Normal | Industrials | United Kingdom | 5 / 6 | $39M |
| Toyo Drilube Co., Ltd. 4976.T | 23 | Normal | Basic Materials | Japan | 4 / 6 | $39M |
| Kanemitsu Corporation 7208.T | 30 | Normal | Consumer Cyclical | Japan | 5 / 6 | $39M |
| Nephros Inc NEPH | 22 | Normal | Healthcare | United States | 6 / 6 | $39M |
| geechs inc. 7060.T | 33 | Normal | Technology | Japan | 5 / 6 | $39M |
| Baguio Green Group Limited 1397.HK | 36 | Normal | Industrials | Hong Kong | 5 / 6 | $39M |
| CRESTEC Inc. 7812.T | 37 | Normal | Industrials | Japan | 5 / 6 | $39M |
| DM Solutions Co.,Ltd 6549.T | 35 | Normal | Communication Services | Japan | 5 / 6 | $39M |
| Manhattan Bridge Capital Inc LOAN | 33 | Normal | Real Estate | United States | 3 / 6 | $39M |
| Fuva Brain Limited 3927.T | 33 | Normal | Technology | Japan | 5 / 6 | $39M |
| Aallon Group Oyj AALLON | 35 | Normal | Industrials | Finland | 5 / 6 | $39M |
| Car Mate Mfg. Co., Ltd. 7297.T | 38 | Normal | Consumer Cyclical | Japan | 5 / 6 | $39M |
| Aurora Mobile Ltd JG | 39 | Normal | Technology | China | 5 / 6 | $39M |
| Globee Inc. 5575.T | 20 | Normal | Technology | Japan | 5 / 6 | $39M |
| MIND Technology Inc MIND | 35 | Normal | Technology | United States | 6 / 6 | $39M |
| Verite Co., Ltd. 9904.T | 36 | Normal | Consumer Cyclical | Japan | 5 / 6 | $39M |
| Petrolia SE PSE.OL | 38 | Normal | Energy | Cyprus | 5 / 6 | $38M |
| Molitec Steel Co., Ltd. 5986.T | 39 | Normal | Basic Materials | Japan | 5 / 6 | $38M |
| Nido Education Ltd NDO | 34 | Normal | Consumer Defensive | Australia | 4 / 6 | $38M |
| STOCK3 AG NA O.N. BOG | 36 | Normal | Industrials | Germany | 4 / 6 | $38M |
| Nomura System Corporation Co, Ltd. 3940.T | 32 | Normal | Technology | Japan | 4 / 6 | $38M |
| Logos Holdings Inc. 205A.T | 30 | Normal | Consumer Cyclical | Japan | 5 / 6 | $38M |
| Precipio Inc PRPO | 33 | Normal | Healthcare | United States | 5 / 6 | $38M |
| KG Intelligence CO., LTD. 2408.T | 33 | Normal | Communication Services | Japan | 4 / 6 | $38M |
| CHINA MAPLE LE.ED.HD0005 CML1 | 31 | Normal | Consumer Defensive | China | 5 / 6 | $38M |
| AB Builders Group Limited 1615.HK | 39 | Normal | Industrials | Macau | 5 / 6 | $38M |
| MOONBAT Co.,Ltd. 8115.T | 37 | Normal | Consumer Cyclical | Japan | 5 / 6 | $38M |
| Scynexis Inc SCYX | 31 | Normal | Healthcare | United States | 3 / 6 | $38M |
| Biohit Oyj B BIOBV | 28 | Normal | Healthcare | Finland | 5 / 6 | $38M |
| MUELLER-LILA LOGIST MLL | 35 | Normal | Industrials | Germany | 5 / 6 | $38M |
| Sinco Pharmaceuticals Holdings Limited 6833.HK | 36 | Normal | Healthcare | China | 5 / 6 | $38M |
| Swiss Properties Invest A/S SWISS | 36 | Normal | Real Estate | Denmark | 4 / 6 | $38M |
| In Construction Holdings Limited 1500.HK | 28 | Normal | Industrials | Hong Kong | 5 / 6 | $38M |
| SYS Holdings Co., Ltd. 3988.T | 30 | Normal | Technology | Japan | 5 / 6 | $38M |
| Lincotrade & Associates Holdings Limited BFT.SI | 34 | Normal | Industrials | Singapore | 5 / 6 | $38M |
| Convenience Retail Asia Limited 0831.HK | 39 | Normal | Consumer Defensive | Hong Kong | 5 / 6 | $37M |
| Xinchen China Power Holdings Limited 1148.HK | 39 | Normal | Consumer Cyclical | Hong Kong | 5 / 6 | $37M |
| Precision System Science Co., Ltd. 7707.T | 36 | Normal | Healthcare | Japan | 4 / 6 | $37M |
| Niraku GC Holdings, Inc. 1245.HK | 33 | Normal | Consumer Cyclical | Japan | 5 / 6 | $37M |
| Oi Electric Co., Ltd. 6822.T | 35 | Normal | Technology | Japan | 5 / 6 | $37M |
| JMACS Japan Co., Ltd. 5817.T | 33 | Normal | Technology | Japan | 5 / 6 | $37M |
| Pharmarise Holdings Corporation 2796.T | 26 | Normal | Healthcare | Japan | 5 / 6 | $37M |
| Just Planning Inc. 4287.T | 27 | Normal | Technology | Japan | 4 / 6 | $37M |
| Vallianz Holdings Limited WPC.SI | 36 | Normal | Industrials | Singapore | 5 / 6 | $37M |
| Left Field Printing Group Limited 1540.HK | 36 | Normal | Industrials | Hong Kong | 5 / 6 | $37M |
| ChatPlus Co.,Ltd. 598A.T | 27 | Normal | Technology | Japan | 4 / 6 | $37M |
| Netgem SA ALNTG | 39 | Normal | Technology | France | 5 / 6 | $37M |
| Besunyen Holdings Company Limited 0926.HK | 38 | Normal | Consumer Defensive | China | 5 / 6 | $37M |
| Human Health Holdings Limited 1419.HK | 35 | Normal | Healthcare | Hong Kong | 5 / 6 | $37M |
| MS Group Holdings Limited 1451.HK | 33 | Normal | Consumer Cyclical | Hong Kong | 5 / 6 | $37M |
| THE WHY HOW DO COMPANY, Inc. 3823.T | 38 | Normal | Technology | Japan | 4 / 6 | $36M |
| Cardiff Property PLC CDFF | 26 | Normal | Real Estate | United Kingdom | 4 / 6 | $36M |
By sector
Industrials 3,117Technology 2,426Consumer Cyclical 2,231Healthcare 1,696Basic Materials 1,056Consumer Defensive 1,055Real Estate 1,011Communication Services 956Energy 487Utilities 343Financial Services 91
How the reading is built
Each company is scored on six mechanisms -- market expectation, operating pressure, cash conversion, leverage, concentration and competitive position -- from its own filed statements. A mechanism whose inputs do not clear its coverage floor is left unread rather than scored zero, and a reading built on thin coverage is pulled toward a neutral prior rather than claiming safety from what nobody looked at.
Descriptive, not advisory. These bands describe measured mechanisms; they are not investment advice, not a forecast, and not a statement about whether a share is worth owning.